| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.1M | +21.7% | +89.9% |
| Cost of Revenue | $4.6M | +31.2% | -44.3% |
| Gross Profit | $3.5M | +11.1% | +185.6% |
| R&D Expense | $7.8M | +0.6% | -26.4% |
| SG&A Expense | $15.3M | +57.4% | +85.6% |
| Operating Income | -$19.6M | -36.8% | +14.2% |
| Interest Expense | $3.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $34.5M | +9.3% | +27.1% |
| Short-term Investments | $76.5M | -19.4% | +61.5% |
| Accounts Receivable | $7.2M | +39.5% | — |
| Inventory | $6.3M | +34.1% | +97.2% |
| Current Assets | $131.3M | -7.3% | +49.7% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$41.2M | — | — |
| Investing Cash Flow | -$76.1M | — | — |
| Financing Cash Flow | $77.1M | — | — |
| — |
| — |
| Income Tax | $0 | — | — |
| Net Income | -$19.5M | -34.7% | +18.5% |
| EPS (Basic) | -$0.43 | -2050.0% | -975.0% |
| EPS (Diluted) | -$0.43 | -2050.0% | -975.0% |
| $139.9M |
| -6.9% |
| +45.3% |
| Current Liabilities | $21.1M | +42.6% | -40.7% |
| Long-term Debt | $35.3M | +0.1% | +2.4% |
| Total Liabilities | $61.8M | +11.2% | -18.6% |
| Stockholders' Equity | $78.2M | -17.5% | +555.0% |